Morphogens and growth factor signalling in the myeloma bone-lining niche
Multiple myeloma is a malignancy caused by the clonal expansion of abnormal plasma cells. Myeloma cells have proven to be incredibly successful at manipulating their microenvironment to promote growth and to evade modern therapies. They have evolved to utilise the integral signalling pathways of the...
Autors principals: | Morris, EV, Edwards, CM |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Springer
2021
|
Ítems similars
-
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease
per: Gooding, S, et al.
Publicat: (2019) -
PB2082: BONE MORPHOGENIC PROTEIN-6 PROMOTES THE PROLIFERATION AND INHIBITS APOPTOSIS IN MULTIPLE MYELOMA
per: Jiaqi Fu, et al.
Publicat: (2023-08-01) -
Myeloma and marrow adiposity: Unanswered questions and future directions
per: Morris, EV, et al.
Publicat: (2021) -
The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo
per: Gámez, B, et al.
Publicat: (2021) -
Notch3 signaling between myeloma cells and osteocytes in the tumor niche promotes tumor growth and bone destruction
per: Hayley M. Sabol, et al.
Publicat: (2022-06-01)